CareMax, Inc. Warrant
CMAXW
CMAXW was delisted on the 27th of November, 2024.
15 hedge funds and large institutions have $645K invested in CareMax, Inc. Warrant in 2023 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 4 increasing their positions, 0 reducing their positions, and 1 closing their positions.
6% less funds holding
Funds holding: 16 → 15 (-1)
43% less capital invested
Capital invested by funds: $1.12M → $645K (-$479K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LP
LMR Partners
London,
United Kingdom
|
+$5.84K |
| 2 |
CL
CSS LLC
Chicago,
Illinois
|
+$2.04K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$510 |
| 4 |
CS
Clear Street
New York
|
+$26 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$5.66K |
CMAXW Hedge Fund Activity: Q3 2023 in Review
15 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in CareMax, Inc. Warrant (CMAXW) for Q3 2023, worth a combined $645K — down 43% from $1.12M a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of CMAXW and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 4 added.
The largest buyer was LMR Partners, adding an estimated $5.84K. The largest seller was Wolverine Asset Management, exiting entirely with an estimated $5.66K sold.
- 15 institutional investors held CareMax, Inc. Warrant (CMAXW) as of Q3 2023, down from 16 in Q2 2023.
- Funds reported $645K of CareMax, Inc. Warrant stock for Q3 2023, down 43% quarter-over-quarter.
- 0 funds opened new CareMax, Inc. Warrant positions in Q3 2023 and 1 closed out, a net change of -1 holder.
- The largest CareMax, Inc. Warrant buyer in Q3 2023 was LMR Partners, an estimated $5.84K added.
- The largest CareMax, Inc. Warrant seller in Q3 2023 was Wolverine Asset Management, an estimated $5.66K sold.
Based on aggregated 13F filings for Q3 2023.